BIO-TECHNE Corp - COMMON STOCK (TECH)

Historical Holders from Q3 2014 to Q3 2025

Symbol
TECH on Nasdaq
CUSIP
09073M104
Type / Class
Equity / COMMON STOCK
Shares outstanding
152M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
159M
Holdings value
$8.84B
% of all portfolios
0.012%
Grand Portfolio weight change
+0%
Number of holders
561
Number of buys
302
Number of sells
-250
Average Value change %
0%
Average buys %
+0.002%
Average sells %
-0.005%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of BIO-TECHNE Corp - COMMON STOCK (TECH)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 7% $537M 11M BlackRock, Inc. Jun 30, 2025
PRICE T ROWE ASSOCIATES INC /MD/ 2.2% -56.7% $186M -$306M 3.35M -62.1% T. Rowe Price Associates, Inc. Sep 30, 2025

Institutional Holders of BIO-TECHNE Corp - COMMON STOCK (TECH)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 159M $8.84B +$43.8M $55.63 561
2025 Q2 159M $8.16B -$119M $51.45 549
2025 Q1 160M $9.4B +$179M $58.63 566
2024 Q4 157M $11.3B +$202M $72.03 564
2024 Q3 153M $12.2B -$146M $79.93 554
2024 Q2 156M $11.2B -$58.2M $71.65 564
2024 Q1 157M $11.1B +$61.4M $70.39 545
2023 Q4 3.94M $304M -$11.1M $77.16 6
2023 Q3 150M $10.2B +$32.5M $68.07 516
2023 Q2 149M $12.2B +$77.7M $81.63 513
2023 Q1 146M $10.8B -$105M $74.19 532
2022 Q4 150M $12.4B +$9.09B $82.88 529
2022 Q3 37.7M $10.7B +$240M $284.00 510
2022 Q2 37.2M $12.9B -$189M $346.64 527
2022 Q1 37.7M $16.3B +$325M $433.04 541
2021 Q4 35.6M $18.4B +$19.4M $517.34 551
2021 Q3 35.5M $17.2B +$86.3M $484.57 548
2021 Q2 35.4M $16B +$196M $450.26 502
2021 Q1 35.2M $13.4B +$222M $381.93 455
2020 Q4 34.7M $11B -$16.1M $317.55 421
2020 Q3 34.9M $8.66B -$30.6M $247.73 405
2020 Q2 36.4M $9.6B -$62.5M $264.07 381
2020 Q1 36.6M $6.94B +$120M $189.62 349
2019 Q4 35.8M $7.85B -$46M $219.51 362
2019 Q3 35.8M $7.01B +$106M $195.67 327
2019 Q2 34.8M $7.25B +$157M $208.49 357
2019 Q1 35.5M $7.05B +$14M $198.55 342
2018 Q4 35.2M $5.09B -$114M $144.72 312
2018 Q3 35.8M $7.31B +$16.7M $204.11 332
2018 Q2 36M $5.33B +$129M $147.95 331
2018 Q1 35.9M $5.42B -$28.8M $151.04 324
2017 Q4 36.4M $4.71B -$40M $129.55 287
2017 Q3 36.8M $4.45B -$55.3M $120.89 278
2017 Q2 37.3M $4.38B +$211M $117.50 269
2017 Q1 36.5M $3.71B +$393M $101.65 265
2016 Q4 35.9M $3.7B +$12.7M $102.83 269
2016 Q3 35.8M $3.91B -$132M $109.50 276
2016 Q2 36.9M $4.16B -$54.1M $112.77 274
2016 Q1 37.4M $3.53B +$22.1M $94.52 250
2015 Q4 37.1M $3.34B +$88.9M $90.00 254
2015 Q3 36.3M $3.35B -$38.1M $92.46 243
2015 Q2 36.3M $3.58B +$15.2M $98.47 236
2015 Q1 36.5M $3.66B +$73.8M $100.29 242
2014 Q4 36.1M $3.33B +$2.87B $92.40 252
2014 Q3 4.95M $463M +$463M $93.55 24